Coming up: earnings from AMD, Palantir, top pharmaceutical and tech firms; private-sector employment report; consumer sentiment.

During IDWeek 2025 in Atlanta, Georgia, Loren G. Miller, MD, MPH, investigator at The Lundquist Institute for Biomedical ...

Saudi Arabia has made the health care and pharmaceuticals industry a priority as it looks to improve citizens’ health and ...

Beijing has unveiled a plan for its International BioPark in the Beijing Economic-Technological Development Area, also known ...

The stock makes the Nasdaq top gainers list today on news of Commercial Sales and Fulfillment of First Orders for Arbli. The stock is trading at $1.3200, +0.7485, gaining over 129% on volume of over ...

Conestoga Capital Advisors, an asset management company, released its third-quarter 2025 investor letter. A copy of the ...

Preseason polls are coming in fast and the majority of them see big things out of the Texas Tech basketball team in the 2025-26 season. The Associated Press Top 25 preseason poll was released Monday ...

In the whirling madness that began when the smartphone achieved ubiquity around 2012, a great many parents did not know what to do. There was massive pressure to give children phones, laptops and ...

Shares of Telomir Pharmaceuticals Inc (NASDAQ:TELO) rose sharply in pre-market trading after the company released promising preclinical study results for its lead compound, Telomir-1. In an SEC Form 8 ...

NEW YORK, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (“Titan” or “TTNP”) today announced the successful closing of its previously announced merger with Black Titan Corporation ...

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) is among the most promising biotech stocks to buy according to hedge funds. According to a recent disclosure with the SEC, Assenagon Asset Management S.A.